Ronald Glaser

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

M. Ronald Glaser, Ph.D, (d. April 3, 2019)[1] was a professor in the Department of Cancer Biology and Genetics and Director of the Institute for Behavioral Medicine Research at the College of Medicine, The Ohio State University, Columbus, Ohio. His main research interests were tumor virology/stress and immunology.[2]

Dr. Glaser advocated that a possible subset of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) could be from viral reactivation following a stressful event.[3] In 2012, Dr Glaser and his team announced work on a possible diagnostic biomarker for CFS that involves the detection of EBV-encoded DNA polymerase and EBV-encoded dUTPase, two proteins that are produced early in the process of Epstein-Barr virus reactivation.[4]

Chronic Fatigue Syndrome Advisory Committee[edit | edit source]

Dr. Glaser served as a voting member of the Chronic Fatigue Syndrome Advisory Committee from 04/01/07 to 04/01/11.[5][6]

2001 CDC Case Definition Workshop[edit | edit source]

In 2001, the CDC held a three-day workshop on Issues Related to the Chronic Fatigue Syndrome (CFS) Research Case Definition. Dr Glaser was one of the invited participants. During the workshop, Dr Glaser gave the presentation: "Immune Modulation by Latent Herpesvirus Proteins."[7]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. "Ronald Glaser - View Obituary & Service Information". Ronald Glaser Obituary. Retrieved April 6, 2019.
  5. (2009), May 27 & 28, 2009 CFSAC Meeting (PDF) (Roster)
  6. (2010), October 12 & 13, 2010 CFSAC Meeting (PDF) (Roster)
  8. Glaser, Ronald; Rice, John; Speicher, Carl E.; Stout, Julie C.; Kiecolt-Glaser, Janice K. (October 1986), "Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity.", Behavioral Neuroscience, 100 (5): 675-678, doi:10.1037/0735-7044.100.5.675
  9. Glaser, R; Kiecolt-Glaser, JK (1998), "Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome.", The American Journal of Medicine, 105 (3A): 35S-42S, PMID 9790480
  10. Glaser, R.; Padgett, D.A.; Litsky, M.L.; Baiocchi, R.A.; Yang, E.V.; Chen, M.; Yeh, P-E.; Klimas, N.G.; Marshall, G.D.; Whiteside, T.; Herberman, R.; Kiecolt-Glaser, J.K.; Williams, M.V. (2005), "Stress-associated changes in the steady state expression of latent Epstein-Barr Virus: Implications for Chronic Fatigue Syndrome and Cancer", Brain, Behavior and Immunity, 19 (2): 91-103, doi:10.1016/j.bbi.2004.09.001, PMID 15664781
  11. Lerner, AM; Ariza, ME; Williams, M; Jason, L; Beqaj, S; Fitzgerald, JT; Lemeshow, S; Glaser, R (2012), "Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset", PLoS ONE, 7 (11): e47891, doi:10.1371/journal.pone.0047891